Institutional investors control 45.44% of the outstanding shares in ARNA. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended March 2017, these large investors purchased a net $27.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GREAT POINT PARTNERS LLC Bought 30.0 Million shares of Arena Pharmaceuticals Inc